BioCentury
ARTICLE | Company News

Huya, Changzhou Center for Biotech Development deal

September 8, 2014 7:00 AM UTC

Huya will have the first opportunity to evaluate R&D projects supported by the Changzhou Center for Biotech Development (CZCBD) in exchange for providing expertise in drug development and commercialization. Huya focuses on establishing collaborations to develop and commercialize China-sourced therapeutic candidates outside of China. CZCBD is a government-funded organization that supports more than 800 biotech and pharma companies within Changzhou. ...